The spread of R plasmids to Neisseria gonorrhoeae and Haemophilus species, which initially lacked them, is a phenomenon which has been well documented (4, 18) . In both cases, indigenous plasmids played an important role in the emergence of antibiotic resistance, either as shuttle vectors for transposons or as mobilization factors for plasmids acquired by transformation (16) . For these reasons, cryptic plasmids are regarded as a potential cause of concern when they are observed in such an important pathogen as Neisseria meningitidis (3, 5, 10, 15, 21) . In fact, there is no reason to believe that the spread of R plasmids to the genus Neisseria will be restricted to N. gonorrhoeae. In this regard, R plasmids have also been recently detected in commensal neisseriae (14, 17) .
We have previously reported the presence of an 8.5-megadalton plasmid in three N. meningitidis strains (7) . The strains, designated Nml, Nm3, and Nm5, had been isolated during a 1-month period from the cerebrospinal fluid (Nml) of a child who died of meningitis and from throat cultures (Nm3 and Nm5) from two healthy schoolmates of the aforementioned child. All strains belonged to serogroup C; were susceptible to ampicillin, penicillin G, cephalothin, chloramphenicol, tetracycline, streptomycin, gentamicin, and rifampin; and were resistant to trimethoprim and sulfamethoxazole (7) . In particular, the MICs of sulfamethoxazole ranged from 512 to >1,024 j±g/ml. Plasmid DNAs from strains Nml, Nm3, and Nm5 were prepared essentially by the method described by Maniatis et al. (13) . Covalently closed circular DNA was isolated by cesium chloride-ethidium bromide density gradient centrifugation, followed by ethanol precipitation. Restriction endonuclease analysis was done with the following enzymes: BamHI, EcoRI, EcoRV, Hinfl, HindII, HindIII, PstI, PvuII, SalI, and SphI (all purchased from Boehringer GmbH, Mannheim, Federal Republic of Germany). The three plasmids were thought to be homologous because no differences in cleavage patterns were observed (Fig. 1) . The plasmid was named pANM1.
Curing experiments were done with strain Nml, to investigate plasmid-encoded functions. The presence of plasmid DNA was established by the rapid method described by Kieser (11) . Treatment with ethidium bromide (10 ,ug/ml) caused a drastic drop (16- was involved in the resistance mechanism of Nml to sulfamethoxazole. This hypothesis was further supported by transformation experiments with Nmlcl, made competent for transformation by using the method described by Sox et al. for N. gonorrhoeae (20) . Transformants were selected on Mueller-Hinton agar (Difco Laboratories, Detroit, Mich.) supplemented with 5% laked horse blood and sulfamethoxazole at various concentrations. DNA obtained from more than 20 sulfamethoxazole-resistant transformed clones and analyzed by using agarose gel electrophoresis showed the constant presence of 8.5-megadalton plasmids.
It has been demonstrated that gram-negative bacteria carrying sulfonamide-resistance plasmids specify dihydropteroate synthetase activity which can function normally in the presence of high concentrations of sulfonamide (9) . To check whether pANM1 encodes dihydropteroate synthetase activity, we transformed Escherichia coli C167ts20 (ura- (Table 2) . Thus, plasmid elimination and transformation experiments clearly demonstrated that the N. meningitidis plasmid pANM1 encodes sulfonamide resistance and that the mechanism of resistance involves a plasmid-encoded dihydropteroate synthetase.
Plasmid-specified resistance to sulfonamides is most often expressed in conjunction with resistance to streptomycin, especially when small plasmids are involved (9) . In contrast, pANM1 does not confer linked sulfonamide-streptomycin resistance. In fact, no differences were observed in the MICs of streptomycin among the parental strain, the cured derivatives, or the transformants (Table 1 ). In connection with this finding, it is worth noting that a 4.9-megadalton plasmid specifying resistance to sulfonamide only has recently been found in Haemophilus ducreyi (1) .
Sulfonamides were standard drugs for therapy and prophylaxis of meningococcal infections until the early 1960s, when epidemics caused by resistant strains first broke out. Since that time, the proportion of resistant strains has increased rapidly (8) . Although the extensive use of a drug is often known to cause plasmid-bearing resistant strains to emerge, and despite the high proportion of sulfonamideresistant meningococci (2, 8) , this is the first reported evidence on the occurrence of sulfonamide plasmids in these organisms. Only cryptic plasmids have been previously described in N. meningitidis (3, 5, 10, 15, 21) , the only exception being a penicillinase-producing plasmid from a urethral isolate, probably acquired by conjugation by a coisolate of N. gonorrhoeae (6).
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